We are live on
!
Find out more
GCGM
General Catalyst Group Management Portfolio holdings
AUM
$189M
1-Year Est. Return
10.96%
This Fund
S&P 500
This Quarter
Est. Return
+19.18%
1 Year Est. Return
-10.96%
3 Year Est. Return
+160.83%
5 Year Est. Return
+123.29%
10 Year Est. Return
–
AUM
$189M
AUM Growth
+$4.95M
(+2.7%)
Cap. Flow
-$22.9M
Cap. Flow
% of AUM
-12.15%
Top 10 Holdings %
Top 10 Hldgs %
98.96%
Holding
16
New
4
Increased
3
Reduced
1
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PBLS
Parabilis Medicines Inc
PBLS
|
+$44.2M |
| 2 |
ODTX
Odyssey Therapeutics
ODTX
|
+$14.2M |
| 3 |
DoorDash
DASH
|
+$471K |
| 4 |
Carvana
CVNA
|
+$457K |
| 5 |
Meta Platforms (Facebook)
META
|
+$405K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Samsara
IOT
|
+$63.4M |
| 2 |
GitLab
GTLB
|
+$19.9M |
| 3 |
Fractyl Health
GUTS
|
+$5 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 79.4% |
| 2 | Consumer Discretionary | 19.35% |
| 3 | Financials | 0.71% |
| 4 | Communication Services | 0.39% |
| 5 | Technology | 0.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
ArriVent BioPharma
AVBP
$1.43B
| $51.9M | 27.55% |
1,494,786
| – | – |
|
|
PBLS
2
Parabilis Medicines Inc
PBLS
$4.56B
| $43.8M | 23.24% |
+1,600,937
| New | +$44.2M |
|
3
Maplebear
CART
$11.3B
| $33.7M | 17.85% |
710,711
| – | – |
|
|
MAZE
4
Maze Therapeutics
MAZE
$1.37B
| $30.9M | 16.4% |
1,035,910
| – | – |
|
|
ODTX
5
Odyssey Therapeutics
ODTX
$1.18B
| $15.2M | 8.04% |
+810,272
| New | +$14.2M |
|
|
EIKN
6
Eikon Therapeutics
EIKN
$484M
| $3.98M | 2.11% |
305,233
| – | – |
|
|
7
Fractyl Health
GUTS
$102M
| $3.88M | 2.06% |
4,884,186
-7
| -0% | -$5 |
|
|
LIFE
8
Ethos Technologies Inc
LIFE
$2.57B
| $1.35M | 0.71% |
74,179
| – | – |
|
9
Coupang
CPNG
$27.2B
| $950K | 0.5% |
54,677
+18,000
| +49% | +$325K |
|
10
Amazon
AMZN
$2.77T
| $925K | 0.49% |
3,882
+1,300
| +50% | +$326K |
|
|
11
Meta Platforms (Facebook)
META
$1.65T
| $744K | 0.39% |
1,320
+662
| +101% | +$405K |
|
|
12
DoorDash
DASH
$87.5B
| $526K | 0.28% |
+2,850
| New | +$471K |
|
|
13
Carvana
CVNA
$49.8B
| $426K | 0.23% |
+6,465
| New | +$457K |
|
|
FIG
14
Figma
FIG
$12.4B
| $269K | 0.14% |
14,845
| – | – |
|
|
15
GitLab
GTLB
$7.83B
| – | – |
-921,405
| Closed | -$19.9M |
|
|
16
Samsara
IOT
$22.5B
| – | – |
-2,000,000
| Closed | -$63.4M |
|
Similar funds
HIM
CCC
MSFP
LWA
ICM
SHC
TFP
BAG
General Catalyst Group Management's Q2 2026 Portfolio in Review
As of Q2 2026, General Catalyst Group Management held 16 positions worth $189M, up 2.7% from $184M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
General Catalyst Group Management withdrew a net $22.9M in Q2 2026, closing 2 positions and reducing 1 holding. Its most notable exit was Samsara, an estimated $63.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, General Catalyst Group Management opened a new position in Parabilis Medicines Inc worth $43.8M.
- General Catalyst Group Management's largest Q2 2026 buy was Parabilis Medicines Inc: 1,600,937 shares worth $43.8M.
- General Catalyst Group Management added most to Meta Platforms (Facebook) in Q2 2026, an estimated $405K increase.
- General Catalyst Group Management's biggest Q2 2026 reduction was Fractyl Health, cutting an estimated $5.
- General Catalyst Group Management fully exited Samsara in Q2 2026, selling an estimated $63.4M.
- General Catalyst Group Management's ten largest holdings make up 99% of its $189M portfolio in Q2 2026.
- General Catalyst Group Management opened 4 new positions and closed 2 in Q2 2026.
- General Catalyst Group Management's portfolio value rose 2.7% quarter-over-quarter to $189M.
Based on General Catalyst Group Management's 13F filing for Q2 2026, filed 17 Aug 2026.